Brentuximab Vedotin Biosimilar - Research Grade
Product Specifications
Background
Brentuximab vedotin is an ADC consisting of a CD30-directed antibody and Monomethyl auristatin E (MMAE) that inhibits CD30-positive cells and is used for the study of relapsed and refractory Hogkin's lymphoma.
Product Name Alternative
MMAE
Host
CHO Cells
Reactivity
Human
Target
TNFRSF8 / CD30
Isotype
IgG1
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
More Discoveries
Explore Other Products
Browse additional items from our catalog
![Human Monoclonal CD11a/CD18 Antibody (Scripps patent anti-CD11a) [Janelia Fluor 635]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
NBP3-28609JF635 0.1 mL
Human Monoclonal CD11a/CD18 Antibody (Scripps patent anti-CD11a) [Janelia Fluor 635]
Sign In for Pricing
View Details 
